Carmen Berasain researcher
Berasain, Carmen
VIAF ID: 246152636130720050014 (Personal)
Permalink: http://viaf.org/viaf/246152636130720050014
Preferred Forms
- 100 1 _ ‡a Berasain, Carmen
- 100 0 _ ‡a Carmen Berasain ‡c researcher
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
5'-methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes. | |
ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia | |
Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. | |
Amphiregulin Aggravates Glomerulonephritis via Recruitment and Activation of Myeloid Cells | |
Amphiregulin: an early trigger of liver regeneration in mice. | |
Amphiregulin induces the alternative splicing of p73 into its oncogenic isoform DeltaEx2p73 in human hepatocellular tumors. | |
Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications. | |
Chromatin dynamics during liver regeneration | |
Conflicting relationship between platelets and prognosis of hepatocellular carcinoma: is platelet-derived serotonin involved in? | |
Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation | |
Deciphering liver zonation: new insights into the β-catenin, Tcf4, and HNF4α triad | |
Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis | |
Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides | |
Differential regulation of the JNK/AP-1 pathway by S-adenosylmethionine and methylthioadenosine in primary rat hepatocytes versus HuH7 hepatoma cells. | |
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis | |
Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis | |
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma | |
The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis | |
The epidermal growth factor receptor: a link between inflammation and liver cancer. | |
The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. | |
Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis | |
Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities | |
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? | |
Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function | |
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. | |
Fibroblast growth factors 19 and 21 in acute liver damage. | |
Further evidence on the janus-faced nature of the epidermal growth factor receptor: From liver regeneration to hepatocarcinogenesis. | |
Genetic analysis of Salmonella enteritidis biofilm formation: critical role of cellulose. | |
Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-kappaB nuclear translocation. | |
Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis | |
Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice | |
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development | |
Impairment of pre-mRNA splicing in liver disease: mechanisms and consequences. | |
In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb. | |
Influence of impaired liver methionine metabolism on the development of vascular disease and inflammation. | |
Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells. | |
Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice. | |
LKB1: Controlling Quiescence and Genomic Integrity at Home. | |
LKB1, gatekeeper of hepatocyte proliferation and genomic integrity. | |
Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma | |
Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14. | |
Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis | |
Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair | |
Methylthioadenosine reverses brain autoimmune disease | |
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis | |
Molecular profiling of hepatocellular carcinoma in mice with a chronic deficiency of hepatic s-adenosylmethionine: relevance in human liver diseases | |
Multipotent Adult Progenitor Cells (MAPC) contribute to hepatocarcinoma neovasculature. | |
New molecular interactions of c-Myc in cholangiocarcinoma may open new therapeutic opportunities. | |
Novel role for amphiregulin in protection from liver injury | |
Oncogenic role of the DLK1/DIO3 locus in beta-catenin dependent liver carcinogenesis. | |
Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice | |
Overcoming class II-linked non-responsiveness to hepatitis B vaccine | |
Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach | |
Platelet-derived growth factor D: a new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts. | |
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease. | |
Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation | |
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma | |
Regulation of amphiregulin gene expression by β-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system | |
Regulation of hepatocyte identity and quiescence. | |
Rôle du locus DLK1/DI03 dans la cancérogenèse hépatique dépendante de la β-caténine | |
S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver | |
SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. | |
Simple strategy to induce antibodies of distinct specificity: Application to the mapping of gp120 and inhibition of HIV-1 infectivity | |
Splicing alterations contributing to cancer hallmarks in the liver: central role of dedifferentiation and genome instability | |
Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins | |
Splicing regulator SLU7 is essential for maintaining liver homeostasis | |
Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression | |
Targeting CCL2/CCR2 in Tumor-Infiltrating Macrophages: A Tool Emerging Out of the Box Against Hepatocellular Carcinoma | |
Targeting the correct target in HCC. | |
Treatment of murine fulminant hepatitis with genetically engineered endothelial progenitor cells | |
Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice. | |
Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy. |